TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CRDF

Cardiff Oncology Inc

Healthcare · Biotechnology

1.20$ -3.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Cardiff Oncology Inc (CRDF) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 37 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CRDF
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
88 82 74 66 63 97 85 76 64 62 49 37
84 77 70 62 59 95 83 74 62 60 47 36
15 22 19 26 13 51 24 11 10 17 8.5 9.2
81 75 67 60 58 92 80 71 61 58 46 35
0.2 0.3 0.4 0.5 0.6 0.8 0.4 0.5 0.3 0.2 0.2 0.2
– – 0.0 – – – – – – – – –
11 12 13 14 14 14 14 17 15 16 14 11
9.0 10 12 13 13 13 13 17 15 16 14 11
0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.6 0.5
2.2 2.0 5.2 5.1 4.6 4.8 3.6 6.0 2.4 8.1 5.5 4.0
78 70 61 52 49 83 71 59 49 45 35 27
-330 -340 -349 -361 -372 -384 -398 -412 -423 -430 -442 -452
45 45 45 45 47 48 48 67 67 67 68 68

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?